Glycopyrrolate Related Clinical Trials
Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation [Completed]
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G) [Recruiting]
Study is to Determine the Extent of Pulmonary Absorption of Glycopyrrolate Following Dosing Via eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (GOLDEN 7) [Not yet recruiting]
Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease [Completed]
Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort [Recruiting]
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers [Completed]
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate [Completed]
Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease [Not yet recruiting]
Efficacy of Fixed Combination of Beclomethasone + Formoterol + Glycopyrrolate Versus Foster® in Chronic Obstructive Pulmonary Diseases [Active, not recruiting]
Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD [Completed]
Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers [Completed]
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD [Recruiting]
Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions [Completed]
Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients [Completed]
Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children [Completed]
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy" [Recruiting]
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. [Completed]
Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) [Recruiting]
Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD [Completed]
Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981) [Completed]
Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD Patients [Completed]
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular Blockade [Recruiting]
Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block [Completed]
PK Study of PT003 and PT001 in Japanese Healthy Subjects [Completed]
Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients [Completed]
Intranasal Administration of a Prokinetic for Bowel Evacuation in Persons With SCI [Completed]
Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration [Completed]
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease [Active, not recruiting]
CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity [Completed]
Chronotropic Incompetence in Patients With HFpEF [Recruiting]
Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD [Recruiting]
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Completed]
Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy [Recruiting]
Anticholinergic Premedication Induced Fever in Pediatric Ambulatory Anesthesia With Ketamine [Completed]
Anesthetics in Rhytidoplasty - A Comparison Study [Completed]
Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers [Completed]
Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage [Completed]
Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma [Recruiting]
Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2) [Completed]
A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo [Completed]
QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation [Completed]
A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Pharmacokinetics and Safety Study of PT010 in Healthy Subjects [Completed]
Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Use of Prokinetics During Inpatient Bowel Care for SCI Patients [Recruiting]
Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI [Recruiting]
Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Sugammadex and Brain Waves [Completed]
Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) [Completed]
Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Completed]
Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients [Not yet recruiting]
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in COPD Patients [Not yet recruiting]
Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort [Not yet recruiting]
Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Efficacy of Peripheral Nerve Stimulator in Assessing Sensory Nerve Block Level of Spinal Anesthesia [Active, not recruiting]
A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. [Completed]
24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI [Active, not recruiting]
24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva� Respimat� as an Active Control, and Placebo [Active, not recruiting]
Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Randomized, Crossover Safety and Pharmacokinetics Study of PT010 [Completed]
Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos) [Recruiting]
Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service [Completed]
A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® [Not yet recruiting]
Drug-drug Interaction Study of CHF5993 With Cimetidine [Completed]
Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD [Recruiting]
Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade [Not yet recruiting]
Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Functional Respiratory Imaging After Neostigmine or Sugammadex [Completed]
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD [Completed]
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD [Recruiting]
Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) [Recruiting]
A Study to Assess the Long-term Safety of QVA149 [Completed]
A Study of the Efficacy and Safety of EP-101 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease [Completed]
Comparison of Org 25969 With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (19.4.301)(P05960) [Completed]
Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)(COMPLETED) [Completed]
The Effect of Deep Block Versus Moderate Block on the Stress Response After Laparoscopic Gastrectomy [Enrolling by invitation]
Balanced Anesthesia for Intubation of Premature Infants [Completed]
A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149 [Completed]
Efficacy and Safety Study of QVA149 in COPD Patients [Not yet recruiting]
Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers [Not yet recruiting]
Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor [Completed]
Measurement of Autonomic Cardiovascular Integrity in Persons With SCI [Recruiting]
Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3) [Completed]
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease [Completed]
Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction [Not yet recruiting]
Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002 [Terminated]
Randomized Controlled Trial Comparing Postoperative Pain Following TAH With GA vs. Combined GA + SAB [Withdrawn]
Long Term Safety Study of NVA237 vs QAB149 in COPD Patients [Completed]
|